GSK (GSK) Long-Term Capital Lease Obligation

: $1,330 Mil (As of Dec. 2023)

View and export this data going back to 1987. Start your Free Trial

GSK's Long-Term Capital Lease Obligation for the quarter that ended in Dec. 2023 was $1,330 Mil.

GSK's quarterly Long-Term Capital Lease Obligation stayed the same from Jun. 2023 ($0 Mil) to Sep. 2023 ($0 Mil) but then increased from Sep. 2023 ($0 Mil) to Dec. 2023 ($1,330 Mil).

GSK's annual Long-Term Capital Lease Obligation declined from Dec. 2021 ($1,080 Mil) to Dec. 2022 ($1,024 Mil) but then increased from Dec. 2022 ($1,024 Mil) to Dec. 2023 ($1,330 Mil).

GSK Long-Term Capital Lease Obligation Historical Data

The historical data trend for GSK's Long-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

GSK Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Long-Term Capital Lease Obligation

1,323.72

1,192.20

1,079.79

1,024.36

1,330.38

GSK Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Long-Term Capital Lease Obligation																1,024.36	-	-	-	1,330.38

GSK (NYSE:GSK) Long-Term Capital Lease Obligation Explanation

Long-Term Capital Lease Obligation are the amount due for long-term asset lease agreements that are nearly equivalent to asset purchases. Capital lease obligations are installment payments that constitute a payment of principal plus interest for the capital lease. The Short-Term Capital Lease Obligation is the portion of a Long-Term Capital Lease Obligation that is due over the next year.

Under US Generally Accepted Accounting Principles (GAAP), a capital lease is essentially equivalent to a purchase by the lessee if it meets the following criteria:

1. Ownership of the asset is transferred to the lessee at the end of the lease term;
2. The lease contains a bargain purchase option to buy the equipment at less than fair market value;
3. The lease term equals or exceeds 75% of the asset's estimated useful life;
4. The present value of the lease payments equals or exceeds 90% of the total original cost of the equipment.

GSK Long-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of GSK's Long-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

GSK (GSK) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » GSK PLC (NYSE:GSK) » Definitions » Long-Term Capital Lease Obligation

Comparable Companies

Traded in Other Exchanges

GLAXF:USA GSK N:Mexico GSKl:UK GSK:UK GS71:Germany GS70:Germany GS71:Germany GS70:Germany GS71:Germany G1SK34:Brazil GSK:Argentina

Address

980 Great West Road, Brentford, Middlesex, GBR, TW8 9GS

Website

https://www.gsk.com

In the pharmaceutical industry, GSK ranks as one of the largest companies by total sales. The company wields its might across several therapeutic classes, including respiratory, cancer, and antiviral, as well as vaccines. GSK uses joint ventures to gain additional scale in certain markets like HIV.